As leaders in the pharmaceutical industry, you understand the true measure of success is reflected in the lives of the patients you serve and the communities you impact. Your innovative solutions and dedication have already earned the trust and gratitude of your customers and patients. Now, it's time for your peers and the broader industry to recognise and celebrate your exceptional achievements.
The Reuters Events Global Pharma Awards is not just another awards ceremony. It uniquely honors those who are transforming patient outcomes, generating unparalleled value for customers, and tackling enduring health inequities. This is an opportunity for your leadership and visionary strategies to be acknowledged on a global scale.
Seize this moment to highlight the outstanding contributions of your team. With eight categories focused on value-based achievements, we invite you to showcase your pioneering work and inspire others. Join us in championing excellence and innovation in the pharmaceutical industry.
This award celebrates your commitment to sustainable development in the pharmaceutical industry.   The winner of this award will be leading an initiative, whether it's in a single project, across multiple initiatives, or by driving change within your organisation. It will be moving moves pharma closer to becoming an industry at the forefront of sustainability. Â
This award celebrates programmes and projects that have helped to reduce health inequalities and had a positive impact on the health of a social, economic or geographic population. The winner of this award will show clear evidence that a specific health inequality was understood and addressed - and that this had a positive impact on the health of the group and therefore contributed to health equity.
This award celebrated your impact of AI systems in helping to solve challenges across the pharmaceutical industry. The award honours organisations and initiatives leveraging AI to revolutionise patient care, diagnostics, treatment planning, drug discovery, and healthcare delivery. Recipients demonstrate exceptional innovation and impact in improving health outcomes and driving efficiencies within the healthcare ecosystem.
This award is for an initiative that has raised the profile and visibility of a disease, cause, health concern, population or treatment. We are not looking to reward mere advertising (no matter how good it is); we are seeking campaigns which have provided additional value, shown creative ways to raise awareness, gathered further reach in an additional way, clarified scientific concepts for HCPs or patients, or made things easier or clearer. Ultimately, we are looking for an authentic effort to educate and further the understanding of something that matters, and that has achieved success in doing so.
This award is for an original product, product enhancement or invention which has the potential and, ideally, early traction to provide significant impact on a patient population. Perhaps it is a newly launched drug showing strong initial results, a new process showing real promise, or a new category or class of treatment that will redefine standard of care in an area. The winner doesn’t need to demonstrate commercial success but needs to show that the product has been launched or will be launched imminently, and that it has disruptive potential with identifiable value for patients, caregivers or health professionals. The winner will be a genuine pioneer, bringing something novel and meaningful to the life sciences industry.Â
The winner of this award will be a project or initiative that has advanced patient outreach and engagement, through digital approaches, post launch. It should demonstrate an iterative approach to product development by identifying and addressing real health requirements prior to and during implementation. The winning project will have met a strong patient need and been managed to an outstanding level, making a quantifiable, positive impact on patients.Â
